Search

everythinglearnresearchcommunity

for

Search:↓

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Taking biotin can lead to incorrect low results in free testosterone tests.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Stopping the drug usually helps, but tamoxifen or surgery may be needed if symptoms persist.

Hormonal therapies might help treat hidradenitis suppurativa, but treatment is complex and personalized.

Adrenal tumors can cause high progesterone levels, mimicking symptoms of high cortisol.

Hypertrichosis lanuginosa causes excessive fine hair growth, often linked to genetics or cancer, with limited treatment options.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Mechanical stimulation and new therapies show promise for hair regrowth.

Estrogen may help improve COVID-19 outcomes, especially in women.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Higher DHEAS levels may cause hair loss in women by disrupting hair growth.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

During puberty, hormone levels rise, with early increases in some steroids and most menstrual cycles becoming regular by six years after menarche.

Sex hormones, especially androgens, play a key role in causing acne.

Growth hormone therapy boosts androgen effects on skin in men.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Cyclosporin A does not change sex hormone levels.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Thyroid function may influence hair loss after COVID-19.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.